After AstraZeneca admits Covid-19 vaccine side effect, Gujarat Congress lashes out at Centre for not maintaining vaccination database
The Indian Express -

Gujarat Congress president Shaktisinh Gohil on Wednesday accused the BJP-led Centre of ignoring the World Health Organization's emergency guidelines to maintain a database of people who have been administered Covid-19 vaccines. Gohil's remarks came a day after global pharmaceutical manufacturer AstraZeneca admitted that its Covid-19 vaccine, developed by researchers from Oxford University, can cause Thrombosis with Thrombocytopenia Syndrome (TTS), a rare side effect of blood clotting and low...

In related news

  • AstraZeneca admits its COVID vaccine can cause rare side effect

    A big update has emerged in connection with COVID vaccine and its rare side effects, which are being questioned by several health experts. British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca has admitted in court papers that its COVID vaccine, Covishield, can cause rare side effect, The Telegraph reported.Covishield was developed by AstraZeneca and was produced by the Serum Institute of India. In India, it was one of the widely administered COVID vaccine.What did...

  • AstraZeneca admits its Covid vaccine can cause rare side effects

    AstraZeneca, in a significant turn, has admitted for the first time in court documents that its Covid-19 vaccine may lead to a rare side effect.The Oxford–AstraZeneca Covid vaccine was sold globally under the brand names Covishield and Vaxzevria among others. The pharmaceutical company faces a class-action lawsuit alleging serious injuries and deaths resulting from its vaccine, developed in collaboration with the University of Oxford. Several families, through the court complaint, alleged that...

  • In a first, AstraZeneca admits its Covid vaccine Covishield can cause rare side effects

    AstraZeneca, for the first time, admitted in its court documents that its Covid vaccine can cause rare side effects, paving way for a multi-million pound legal payout, The Telegraph reported on Sunday. The pharmaceutical company is being sued in a class action over claims that its vaccine against Covid-19, developed with the University of Oxford, caused death and serious injury, including TTS — Thrombosis with Thrombocytopenia Syndrome — which causes people to have blood clots and a low blood...